APA (7th ed.) Citation

CJP, O. '. H., N, M., B, v. d. W., E, O., DM, S., IM, v. O., . . . E, B. (2026). Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer. Clinical pharmacokinetics, 65(5), 763. https://doi.org/10.1007/s40262-026-01640-6

Chicago Style (17th ed.) Citation

CJP, Op 't Hoog, Mehra N, van der Weij B, Olofsen E, Somford DM, van Oort IM, Hamberg P, van Erp NP, and Boerrigter E. "Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer." Clinical Pharmacokinetics 65, no. 5 (2026): 763. https://doi.org/10.1007/s40262-026-01640-6.

MLA (9th ed.) Citation

CJP, Op 't Hoog, et al. "Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer." Clinical Pharmacokinetics, vol. 65, no. 5, 2026, p. 763, https://doi.org/10.1007/s40262-026-01640-6.